Lumos Pharma, Inc.

Historical 13F Holders

Symbol
LUMO
CUSIP
55028X109
All holders as of
Q3 2024
Type
Equity
Class
COM
Reported Value, Excluding Options
Total Filings

13D/G Filers

Investors who own more than 5% of a class must file a Schedule 13D or 13G. Each filer's latest filing for 55028X109 since 12/18/2024, largest first.

Filer % of Class Filed
Under 5%, checked the "5 percent or less" box, or amended by a later filing (3)
Wells Fargo & Company/MN 13G/A 0.8% 10/25/2024
Event 9/30/2024
Goldman Sachs Group Inc 13G/A
0% 2/13/2025
Event 12/31/2024
Private Advisor Group, LLC 13G/A 0% 2/13/2025
Event 12/31/2024

13F Holders by Quarter

Period Filings Shares, Excl. Options Value, Excl. Options
2024 Q3 31 2.09 M $8.08 M
2024 Q2 40 2.08 M $4.82 M
2024 Q1 41 2.18 M $6.14 M
2023 Q4 41 2.77 M $8.81 M
2023 Q3 36 2.44 M $8.05 M
2023 Q2 37 2.39 M $7.90 M
2023 Q1 39 2.23 M $7.40 M
2022 Q4 42 2.42 M $9.28 M
2022 Q3 37 2.56 M $23.0 M
2022 Q2 41 2.40 M $18.8 M
2022 Q1 38 2.48 M $23.3 M
2021 Q4 40 2.70 M $18.7 M
2021 Q3 38 2.87 M $27.3 M
2021 Q2 42 3.20 M $32.1 M
2021 Q1 44 3.32 M $38.8 M
2020 Q4 50 3.81 M $136 M
2020 Q3 39 3.64 M $50.2 M
2020 Q2 47 3.56 M $58.7 M
2020 Q1 50 3.28 M $27.9 M